DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.62 (2016) >

Please use this identifier to cite or link to this item: http://ir.fmu.ac.jp/dspace/handle/123456789/520

Files in This Item:

File Description SizeFormat
FksmJMedSci_62_p51.pdf289.47 kBAdobe PDFDownload
Title: Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima Prefecture
Authors: Suzuki, Yuhko
Sato, Taku
Sakuma, Jun
Ichikawa, Masahiro
Kishida, Yugo
Oda, Keiko
Watanabe, Yoichi
Goto, Takeshi
Sato, Masahiro
Nollet, Kenneth E
Saito, Kiyoshi
Ohto, Hitoshi
Affiliation: 輸血・移植免疫学講座
脳神経外科学講座
Source title: Fukushima Journal of Medical Science
Volume: 62
Issue: 1
Start page: 51
End page: 56
Issue Date: 2016
Abstract: We conducted a case series study to assess intracerebral hemorrhage (ICH) in the context of anti-platelets agents (APAs) and platelet (PLT) transfusion in Fukushima Prefecture.This study included patients who were newly diagnosed with ICH between January 2008 and June 2014 in the neurosurgical hospitals of Fukushima Prefecture. Four of ten neurosurgical hospitals responded to our questionnaire. Of 287 ICH patients, 51 (20.6%) were on APA therapy, of whom PLT transfusion was given to only one persistently bleeding patient who was on dual anti-platelet therapy. In a follow-up survey, 30 out of 51 ICH patients on APA therapy, average age 75 years, were analyzed, of whom 21 (70%) were male. The predominant underlying disease was diabetes mellitus. It is interesting to note that peripheral artery disease and aortic aneurysm were among the indications for APAs. ICH was mainly observed supratentorially. Hematoma enlargement was observed in 13 (44.8%) cases. By day 7, 3 patients (10%) had died from complications of ICH. In this study, we show that ICH during APA therapy matched what was observed in Kanagawa Prefecture. Whether or not a national survey differs, we anticipate greater statistical validity and an opportunity to improve patient outcomes in Japan and around the world.
Publisher: The Fukushima Society of Medical Science
Publisher (Alternative foam): 福島医学会
language: eng
URI: http://ir.fmu.ac.jp/dspace/handle/123456789/520
Full text URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/520/1/FksmJMedSci_62_p51.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.2015-26
PubMed ID: 27210309
Related Page: http://doi.org/10.5387/fms.2015-26
Rights: © 2016 The Fukushima Society of Medical Science
Appears in Collections:Vol.62 (2016)

Files in This Item:

File Description SizeFormat
FksmJMedSci_62_p51.pdf289.47 kBAdobe PDFDownload

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard